Therefore, focusing on the ability of the Keap1-Nrf2 signaling pathway that exerts intracellular resistance to ferroptosis could help to explore the specific mechanisms which breast cancer cells exhibit chemoresistance. This evidence concerns the gene NFE2L2 and breast cancer.